Shockwave Phonophoresis on Calcaneal Spur Patients

July 18, 2022 updated by: Mostafa Ali Elwan, Beni-Suef University

Effect of Acetic Acid Shockwave Phonophoresis on Calcaneal Spur Patients: A Randomized Controlled Trial

The Low energy shockwave has a significant effect on the permeability of tissue. Consequently, it might be used to deliver a substance such as Acetic acid. Accordingly, Shockwave might help to improve the outcomes with calcaneal spur patients. Therefore, the present study might help in the treatment of calcaneal spur patients and also might improve the quality of life in a fast and efficient way.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

60

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Giza, Egypt
        • Faculty of physical therapy, Cairo University
        • Contact:
        • Principal Investigator:
          • Nabil M Abdel-Aal, PHD
        • Principal Investigator:
          • Fatama SEDDEK, PHD
        • Principal Investigator:
          • Mostafa Elwan, MSc.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

35 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Heel pain with a calcaneal spur.
  • Calcaneal spur in a lateral calcaneal x-ray.
  • Patient's age ranged from 30 to 65 years.
  • Patients with a calcaneal spur.
  • Patients with intact sensory perception.
  • At least 6 weeks from last corticosteroid injection; 4 weeks from the last local anaesthetic injection, iontophoresis, ultrasound, and electrotherapy

Exclusion Criteria:

  • History of fracture or surgery of the heel or ankle.
  • Presence of inflammatory joint disease.
  • Marked osteoporotic patient.
  • Presence of ankylosing spondylitis or other inflammatory joint diseases.
  • Heart pacemaker use.
  • Patient on anticoagulant and coagulation disease.
  • Skin wound or ulcers.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Shock wave Therapy
This group will be composed of subjects who represented the experimental group 1. They will receive shock wave therapy
This group composed of subjects and represented the control group who will receive shock wave therapy
Experimental: Acetic acid shockwave phonophoresis therapy
This group will be composed of subjects who represented the experimental group 2. They will take 6 sessions with Time between sessions 5-7 days plus exercise and dietary advice
This group composed of subjects. They will take 6 sessions with Time between sessions 5-7 days plus exercise and dietary advice
Active Comparator: conventional physical therapy program

This group will be composed of subjects who represented the control group

Exercise program:

  • Standing calf-stretching exercise
  • Towel stretch: stretching exercise
  • Ice bottle
  • Towel pickup exercise
  • Marble pickups exercise
  • Calf raises exercises -Static and dynamic balance exercise

Exercise program:

  • Standing calf-stretching exercise
  • Towel stretch: stretching exercise
  • Ice bottle
  • Towel pickup exercise
  • Marble pickups exercise
  • Calf raises exercises -Static and dynamic balance exercise

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
calcaneal spur length by X-ray (mm)
Time Frame: three months
X-ray on the affected foot to measure the length of the calcaneal spur
three months
calcaneal spur width by X-ray (mm)
Time Frame: three months
X-ray on the affected foot to measure the width of the calcaneal spur
three months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
FPX 50 wagner Pressure pain threshold (PPT)
Time Frame: three months
this device used to measure the pressure pain threshold
three months
Activity of daily living: by Foot and Ankle Ability Measure scale
Time Frame: three months
This scale formed from 29 item, the minimum score for each item is 0 and maximum score is 4 , the Higher scores represent higher levels of function for each subscale, with 100% representing no dysfunction
three months
visual analogue scale.
Time Frame: three months
this scale for pain intensity level assessment and contain minimum score is 0 and maximum score is 100 mm, the higher score indicate more pain (sever dysfunction)
three months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Collaborators

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

August 15, 2022

Primary Completion (Anticipated)

November 15, 2022

Study Completion (Anticipated)

December 15, 2022

Study Registration Dates

First Submitted

April 17, 2022

First Submitted That Met QC Criteria

May 9, 2022

First Posted (Actual)

May 13, 2022

Study Record Updates

Last Update Posted (Actual)

July 19, 2022

Last Update Submitted That Met QC Criteria

July 18, 2022

Last Verified

July 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Calcaneal Spur

Clinical Trials on Shock wave Therapy

Subscribe